195 related articles for article (PubMed ID: 10918061)
1. A structure-function analysis of serine/threonine phosphorylation of the thrombopoietin receptor, c-Mpl.
Miyakawa Y; Drachman JG; Gallis B; Kaushansky A; Kaushansky K
J Biol Chem; 2000 Oct; 275(41):32214-9. PubMed ID: 10918061
[TBL] [Abstract][Full Text] [Related]
2. Studies with chimeric Mpl/JAK2 receptors indicate that both JAK2 and the membrane-proximal domain of Mpl are required for cellular proliferation.
Drachman JG; Miyakawa Y; Luthi JN; Dahlen DD; Raney A; Geddis AE; Kaushansky K
J Biol Chem; 2002 Jun; 277(26):23544-53. PubMed ID: 11980901
[TBL] [Abstract][Full Text] [Related]
3. Differential signalling of NH2-terminal flag-labelled thrombopoietin receptor activated by TPO or anti-FLAG antibodies.
Millot GA; Vainchenker W; Duménil D; Svinarchuk F
Cell Signal; 2004 Mar; 16(3):355-63. PubMed ID: 14687665
[TBL] [Abstract][Full Text] [Related]
4. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
Drachman JG; Kaushansky K
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
[TBL] [Abstract][Full Text] [Related]
5. A novel MPL point mutation resulting in thrombopoietin-independent activation.
Abe M; Suzuki K; Inagaki O; Sassa S; Shikama H
Leukemia; 2002 Aug; 16(8):1500-6. PubMed ID: 12145691
[TBL] [Abstract][Full Text] [Related]
6. The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl.
Drachman JG; Griffin JD; Kaushansky K
J Biol Chem; 1995 Mar; 270(10):4979-82. PubMed ID: 7534285
[TBL] [Abstract][Full Text] [Related]
7. Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.
Rouyez MC; Boucheron C; Gisselbrecht S; Dusanter-Fourt I; Porteu F
Mol Cell Biol; 1997 Sep; 17(9):4991-5000. PubMed ID: 9271377
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine-599 of the c-Mpl receptor is required for Shc phosphorylation and the induction of cellular differentiation.
Alexander WS; Maurer AB; Novak U; Harrison-Smith M
EMBO J; 1996 Dec; 15(23):6531-40. PubMed ID: 8978680
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of the cytoplasmic domain of the human Mpl receptor for tyrosine-phosphorylation of the signaling molecules, proliferation and differentiation.
Morita H; Tahara T; Matsumoto A; Kato T; Miyazaki H; Ohashi H
FEBS Lett; 1996 Oct; 395(2-3):228-34. PubMed ID: 8898102
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin activates a STAT5-like factor in hematopoietic cells.
Pallard C; Gouilleux F; Bénit L; Cocault L; Souyri M; Levy D; Groner B; Gisselbrecht S; Dusanter-Fourt I
EMBO J; 1995 Jun; 14(12):2847-56. PubMed ID: 7796811
[TBL] [Abstract][Full Text] [Related]
11. Internalization of the thrombopoietin receptor is regulated by 2 cytoplasmic motifs.
Dahlen DD; Broudy VC; Drachman JG
Blood; 2003 Jul; 102(1):102-8. PubMed ID: 12623841
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
[TBL] [Abstract][Full Text] [Related]
13. The thrombopoietin receptor c-MPL activates JAK2 and TYK2 tyrosine kinases.
Sattler M; Durstin MA; Frank DA; Okuda K; Kaushansky K; Salgia R; Griffin JD
Exp Hematol; 1995 Aug; 23(9):1040-8. PubMed ID: 7543416
[TBL] [Abstract][Full Text] [Related]
14. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e.
Quentmeier H; Zaborski M; Drexler HG
Leukemia; 1998 Oct; 12(10):1603-11. PubMed ID: 9766506
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction by the peptide which mimics the activity of thrombopoietin.
Kimura T; Kaburaki H; Tsujino T; Watanabe Y; Kato H
Biochem Mol Biol Int; 1998 May; 44(6):1203-9. PubMed ID: 9623775
[TBL] [Abstract][Full Text] [Related]
16. MplK, a natural variant of the thrombopoietin receptor with a truncated cytoplasmic domain, binds thrombopoietin but does not interfere with thrombopoietin-mediated cell growth.
Millot GA; Feger F; Garçon L; Vainchenker W; Dumenil D; Svinarchuk F
Exp Hematol; 2002 Feb; 30(2):166-75. PubMed ID: 11823052
[TBL] [Abstract][Full Text] [Related]
17. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
[TBL] [Abstract][Full Text] [Related]
18. Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin.
Porteu F; Rouyez MC; Cocault L; Bénit L; Charon M; Picard F; Gisselbrecht S; Souyri M; Dusanter-Fourt I
Mol Cell Biol; 1996 May; 16(5):2473-82. PubMed ID: 8628315
[TBL] [Abstract][Full Text] [Related]
19. Thrombopoietin signal transduction requires functional JAK2, not TYK2.
Drachman JG; Millett KM; Kaushansky K
J Biol Chem; 1999 May; 274(19):13480-4. PubMed ID: 10224114
[TBL] [Abstract][Full Text] [Related]
20. Role of the distal half of the c-Mpl intracellular domain in control of platelet production by thrombopoietin in vivo.
Luoh SM; Stefanich E; Solar G; Steinmetz H; Lipari T; Pestina TI; Jackson CW; de Sauvage FJ
Mol Cell Biol; 2000 Jan; 20(2):507-15. PubMed ID: 10611229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
